RSS

Competitions and Markets Authority (CMA)

The Competition and Markets Authority (CMA) has released a statement alleging that drug company, Concordia, has abused its position with the NHS to overcharge for liothyronine tablets — an essential thyroid drug. more

News

The UK’s Competition and Markets Authority (CMA) dishes the two firms a record fine of nearly £90 million for charging excessive prices to the NHS for an anti-epilepsy drug. more

News

China plans to launch a large-scale and systematic investigation into drug firms, both foreign and local, reported state newspaper China Daily more

News

GlaxoSmithKline (GSK), Generics UK (GUK) and Alpharma have been fined £45m by the Competition and Markets Authority (CMA) for anti-competitive conduct and agreements more

News

Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. more

News